Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association.

× No keyword cloud information.

20 in total

Review 1. Percutaneous coronary intervention in diabetics.

Authors: Juhana Karha; Deepak L Bhatt
Journal: Rev Endocr Metab Disord Date: 2004-08 Impact factor: 6.514

Review 2. Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors: P H Winocour
Journal: Postgrad Med J Date: 1991-10 Impact factor: 2.401

3. Modifications of coronary risk factors.

Authors: Jeanine Albu; Sheldon H Gottlieb; Phyllis August; Richard W Nesto; Trevor J Orchard
Journal: Am J Cardiol Date: 2006-04-19 Impact factor: 2.778

4. Epicardial adipose tissue volume as a marker of coronary artery disease severity in patients with diabetes independent of coronary artery calcium: findings from the CTRAD study.

Authors: Dilbahar S Mohar; Jonathan Salcedo; Khiet C Hoang; Shivesh Kumar; Farhood Saremi; Ashwini S Erande; Nassim Naderi; Pradeep Nadeswaran; Christine Le; Shaista Malik
Journal: Diabetes Res Clin Pract Date: 2014-09-06 Impact factor: 5.602

5. Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.

Authors: S Nielsen; O Schmitz; N Møller; N Pørksen; I C Klausen; K G Alberti; C E Mogensen
Journal: Diabetologia Date: 1993-10 Impact factor: 10.122

6. Simvastatin reduces plasma lipid levels and improves insulin action in elderly, non-insulin dependent diabetics.

Authors: G Paolisso; S Sgambato; S De Riu; A Gambardella; M Verza; M Varricchio; F D'Onofrio
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

7. Cardiovascular disease prevention practices by U.S. Physicians for patients with diabetes.

Authors: J B Meigs; R S Stafford
Journal: J Gen Intern Med Date: 2000-04 Impact factor: 5.128

8. Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.

Authors: J Q Purnell; S M Marcovina; J E Hokanson; H Kennedy; P A Cleary; M W Steffes; J D Brunzell
Journal: Diabetes Date: 1995-10 Impact factor: 9.461

Review 9. Preventing long term complications. Implications for combination therapy with acarbose.

Authors: B R Zimmerman
Journal: Drugs Date: 1992 Impact factor: 9.546

Review 10. Omega-3 fatty acids. Current status in cardiovascular medicine.

Authors: E B Schmidt; J Dyerberg
Journal: Drugs Date: 1994-03 Impact factor: 9.546